Goodwin advised Tessera Therapeutics on the deal. Tessera Therapeutics announced its collaboration with Serotiny to engineer programmable Gene Writer proteins. Under the terms of the agreement, Serotiny...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised AbCellera on the deal. AbCellera (Nasdaq: ABCL) announced its acquisition of TetraGenetics. AbCellera is a technology company with a centralized operating system for next-generation...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Envisagenics on the deal. Envisagenics announced its collaboration with Biogen Inc. (Nasdaq: BIIB) to advance ribonucleic acid (RNA) splicing research within central nervous...
You must be a Standard 1 Year member to access this content.
